Literature DB >> 8430830

Characterization of neutral endopeptidase in vascular smooth muscle cells of rabbit renal cortex.

J C Dussaule1, A Stefanski, M L Béa, P Ronco, R Ardaillou.   

Abstract

In addition to biological and clearance receptors for atrial natriuretic factor (ANF), cultured vascular smooth muscle cells (VSMC) from the rabbit renal cortex possess ectoenzymes degrading this hormone. We examined whether neutral endopeptidase (NEP) was implicated in this process. The presence of NEP in VSMC was demonstrated as follows. 1) NEP activity measured from the hydrolysis of a synthetic substrate by intact cells cultured in a medium containing 10% fetal calf serum was 1,609 +/- 65 pmol.min-1 x mg-1 [surface localization of the enzyme was confirmed by low activity (4% of total) in the cytosol; release of NEP activity in the medium was negligible]; 2) a monoclonal antibody directed against rabbit NEP specifically stained VSMC membranes; and 3) mRNA from VSMC hybridized a NEP cDNA probe with a single band as shown by Northern blot analysis. The role of NEP in ANF catabolism was demonstrated by incubating 125I-ANF or unlabeled ANF for increasing periods of time with VSMC in the presence of thiorphan (1-100 microM). Intact hormone estimated by trichloroacetic acid precipitation or radio-immunoassay, respectively, increased markedly compared with control in the presence of this specific inhibitor of NEP. NEP activity was stimulated (x1.6) in quiescent VSMC deprived from serum during 3 days. This effect was dose dependent and was not observed with creatine kinase activity measured as control. NEP expression at the cell surface estimated by sorting of immunostained cells was also increased in the absence of serum. Northern blot analysis showed increases in the mRNA band of NEP with increasing periods of serum deprivation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430830     DOI: 10.1152/ajprenal.1993.264.1.F45

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Interest and limits of in vitro studies in renal vascular endocrinology.

Authors:  M Essig; S Ledoux; P L Tharaux; C Chatziantoniou; J C Dussaule
Journal:  Cell Biol Toxicol       Date:  1996-12       Impact factor: 6.691

Review 2.  Angiotensin II Receptor Blocker Neprilysin Inhibitor (ARNI): New Avenues in Cardiovascular Therapy.

Authors:  M Volpe; G Tocci; A Battistoni; S Rubattu
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-06-23

Review 3.  A podocyte view of membranous nephropathy: from Heymann nephritis to the childhood human disease.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Pflugers Arch       Date:  2017-06-08       Impact factor: 3.657

4.  Effect of endopeptidase-24.11 inhibitors and C-ANP receptor ligand on responses evoked in arterioles of rat cremaster muscle by atrial natriuretic peptide.

Authors:  J Peyroux; F Beslot; N Claperon; M C Fournie-Zaluski; B P Roques
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

5.  Spatio-temporal localization of vasoactive intestinal peptide and neutral endopeptidase in allergic murine lungs.

Authors:  Amali E Samarasinghe; Scott A Hoselton; Jane M Schuh
Journal:  Regul Pept       Date:  2010-06-08

6.  Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts.

Authors:  T Maki; T Horio; F Yoshihara; S Suga; S Takeo; H Matsuo; K Kangawa
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

7.  Bradykinin potentiation by ACE inhibitors: a matter of metabolism.

Authors:  Beril Tom; Andreas Dendorfer; René de Vries; Pramod R Saxena; A H Jan Danser
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

Review 8.  Vasopeptidase inhibitors: will they have a role in clinical practice?

Authors:  Matthew I Worthley; Roberto Corti; Stephen G Worthley
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

Review 9.  Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.

Authors:  P Ronco; H Debiec
Journal:  Semin Immunopathol       Date:  2007-09-26       Impact factor: 9.623

Review 10.  Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics.

Authors:  Sarah Mangiafico; Lisa C Costello-Boerrigter; Ingrid A Andersen; Alessandro Cataliotti; John C Burnett
Journal:  Eur Heart J       Date:  2012-08-31       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.